retatrutide + cagrilintide dosage with Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Retatrutide Starting Dose: What Clinical
Description
Zhang J, Tiller C, Shen J, Wang C, Girouard GS, Dennis D,
Higher doses led to more weight loss, with the top group averaging around a 20% reduction
J Endocrinol 166 : 579590 Coschigano KT et al
LeclercqSCaniPDNeyrinckAMStarkelPJamarFMikolajczakMet al
Incapsula incident ID: 537000100392917642-766917666875703987
The results were unambiguous: 36 total studies were identified, and 35 of them were conducted entirely in animals (Park, 2025)
